Header Logo

Connection

ALEXANDER SANDWEISS to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications ALEXANDER SANDWEISS has written about Drug Evaluation, Preclinical.
ALEXANDER SANDWEISS
Connection Strength
0.026
Drug Evaluation, Preclinical
  1. Novel fentanyl-based dual ?/d-opioid agonists for the treatment of acute and chronic pain. Life Sci. 2013 Dec 18; 93(25-26):1010-6.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.